Диссертация (1139542), страница 54
Текст из файла (страница 54)
‒Published online.Juniper E. F., O'Byrne P. M., Guyatt G. H., Ferrie P. J., King D. R. Development andvalidation of a questionnaire to measure asthma control. // Eur Respir J. ‒ 1999. ‒ V. 14, №4. ‒ P. 902-907.Juniper E. F., O'Byrne P., Ferrie P. J., King D. R., Roberts J. N. Measuring Asthma Control.Clinic Questionnaire or Daily Diary? // Am. J. Respir. Crit. Care Med.
‒ 2000. ‒ V. 162, №4. ‒ P. 1330-1334.Juniper E. F., Svensson K., Mörk A.-C., Ståhl E. Measurement properties and interpretationof three shortened versions of the asthma control questionnaire // Respiratory Medicine. ‒2005. ‒ V. 99, № 5. ‒ P. 553-558.Kaliner M., Shelhamer J. H., et al. "Autonomic nervous system abnormalities and allergy."// Ann. Intern.Med. ‒ 1982. ‒ V.
96. ‒ P. 349-357.Kallenbach J. M., Webster T., al. e. Reflex heart rate control in asthma: evidence ofparasympathetic overactivity. // Chest. ‒ 1985. ‒ V. 87, № 5. ‒ P. 644-648.Kanazawa H., Kurihara H., Hirata K., Takeda T. The role of free radicals in airwayobsruction in asthmatic patients. // Chest. ‒ 1991. ‒ V.
100. ‒ P. 1319-1322.Kapp A., Czech W., Krutmann J., Zeck-Kapp G. Die Actievirung vor Granulocyten desatopischen Formen Kreises. // Allergologie. ‒ 1991. ‒ V. 1. ‒ P. 63.Kay A. B. The role of eosinophils in the pathogenesis of asthma. // Trends Mol Med. ‒2005. № 11. ‒ P. 148-152.Kazani S., Planaguma A., Ono E., Bonini M., al. e. Exhaled breath condensate eicosanoidlevels associate with asthma and its severity.
// J Allergy Clin Immunol. - 2013. ‒ P. 547553.Kelly F. J. Gluthathione: in defence of the lung // Food Chem Toxicol. ‒ 1999. ‒ V. 37, №9-10. ‒ P. 963-966.Kelly F. J., Mudway I., Blomberg A., Frew A., Sandstrom T. Altered lung antioxidant statusin patients with mild asthma // Lancet. ‒ 1999. ‒ V. 354, № 9177. ‒ P. 482-483.Kepley C. L. New approaches to allergen immunotherapy. // Curr Allergy Asthma Rep. ‒2006. ‒ V. 6, № 5. ‒ P. 427-433.Khalili B., Boggs P. B., Shi R., Bahna S. L.
Discrepancy between clinical asthma controlassessment tools and fractional exhaled nitric oxide // Ann Allergy Asthma Immunol. ‒2008. ‒ V. 101, № 2. ‒ P. 124-9.Khanduja K. L., Kaushik G., Khanduja S., Pathak C. M., et al. Corticosteroids affect nitricoxide generation, total free radicals production, and nitric oxide synthase activity inmonocytes of asthmatic patients. // Mol Cell Biochem.
‒ 2011. ‒ V. 346, № 1-2. ‒ P. 31-37.Kharitonov S. A., Barnes P. J. Exhaled markers of inflammation // Curr Opin Allergy Clin303320321322323324325326327328329330331332333334335336337338339Immunol. ‒ 2001. ‒ V. 1, № 3. ‒ P. 217-224.Kim C. K., Chung C. Y., Choi S. J., al. e. Bronchoalveolar lavage cellular composition inacute asthma and acute bronchiolitis.
// J Pediatr ‒2000. ‒ V. 137. ‒ P. 517-522.Kim H. B., Eckel S. P., Kim J. H., Gilliland F. D. Exhaled NO: Determinants and ClinicalApplication in Children With Allergic Airway Disease. // Allergy Asthma Immunol Res. –V8. - №1. - 2016. ‒ C. 12-21.Kim H., Mazza J. Asthma // Allergy Asthma Clin Immunol. ‒ 2011. ‒ V. 7, № (Suppl 1):S2.Kinnula V. L. Production and degradation of oxygen metabolites during inflammatory statesin the human lung // Curr Drug Targets Inflamm Allergy.
‒ 2005. ‒ V. 4, № 4. ‒ P. 465-470.Kinnula V. L., Crapo J. D. Superoxide dismutases in the lung and human lung diseases //Am J Respir Crit Care Med. ‒ 2003. ‒ V. 167, № 12. ‒ P. 1600-1619.Kirkham P., Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeuticstrategy // Pharmacol Ther. ‒ 2006. ‒ V. 111, № 2.
‒ P. 476-94.Kiroiwa A., Igisu K., Yano L., et al. Fibronectin enchances respiratory burst of phagocytesstimulated zimozan and immune complex. // Immunology. ‒ 1988. ‒ V. 65, № 2. ‒ P. 177180.Kobayashi H., Ishibashi K., al. e. Heart Rate Variability; An Index for Monitoring andAnalyzing Human Autonomic Activities. // Applied Human Science. ‒ 1999. ‒ V. 18. ‒ P.253-59Koskela H.
O., Purokivi M. K., Nieminen R. M., al. e. Asthmatic cough and airwayoxidative stress. // Respir Physiol Neurobiol. ‒ 2012. ‒ V.181, №3. –P.346-350.Kostikas K., Papaioannou A. I., Tanou K., et al. Exhaled NO and exhaled breath condensatepH in the evaluation of asthma control. // Respir Med. ‒ 2011. ‒ V. 105. ‒ P. 526-532.Kostikas K., Papaioannou A. I., Tanou K., Koutsokera A., Papala M., Gourgoulianis K.
I.Portable exhaled nitric oxide as a screening tool for asthma in young adults during pollenseason // Chest. ‒ 2008. ‒ V. 133, № 4. ‒ P. 906-913.Kostikas K., Papatheodorou G., Ganas K., Psathakis K., Panagou P., Loukides S. pH inexpired breath condensate of patients with inflammatory airway diseases // Am J Respir CritCare Med. ‒ 2002. ‒ V. 165, № 10. ‒ P. 1364-1370.Kovesi T., Dales R.
Exhaled nitric oxide and respiratory symptoms in a community sampleof school aged children // Pediatr Pulmonol. ‒ 2008. ‒ V. 43, № 12. ‒ P. 1198-1205.Kovesi T., Kulka R., Dales R. Exhaled nitric oxide concentration is affected by age, height,and race in healthy 9- to 12-year-old children // Chest. ‒ 2008. ‒ V. 133, № 1. ‒ P. 169-175.Kuipers I., Louis R., Manise M., et al. Increased glutaredoxin- 1 and decreased protein Sglutathionylation in sputum of asthmatics // European Respiratory Journal.
- 2013. ‒ P. 469472.Lacy P., Latif D. L., Steward M., Musat-Marsu S., Man P., Moqbel R. Divergence ofmechanisms regulating respiratoty burst in blood and sputum eosinophils and neutrophilsfrom atopic subjects. // The Journal of Immunology. ‒ 2003. ‒ V. 170. ‒ P. 2670-2679.Lai L., Hopp R. J., Lusk R. P. Pediatric chronic sinusitis and asthma: a review. // J Asthma.‒ 2006. ‒ V. 43, № 10. ‒ P. 719-725.Larsson K., Carlens P., al. e.
Sympathoadrenal responses to bronchoconstriction in asthma:an invasive and kinetic study of plasma catecholamines. // Clin. Sci. (London). ‒ 1995. ‒ V.88, № 4. ‒ P. 439-446.Larstad M., Ljungkvist G., Olin A.-C., Tor K. Determination of malondialdehyde in breathcondensate by highperformance liquid chromatography with fluorescence detection.
//Journal of Chromatography B: Analytical Technologies in the Biomedical and LifeSciences. - 2002. ‒ P. 107-114.Lärstad М., Toren K., Bake B., Olin A. C. Determination of ethane, pentane and isoprene inexhaled air--effects of breath-holding, flow rate and purified air. // Acta Physiol (Oxf). . ‒2007. ‒ V.
189, № 1. ‒ P. 87-98.304340341342343344345346347348349350351352353354355356357358Lavinskiene S., Jeroch J., Malakauskas K., al. e. Peripheral blood neutrophil activity duringDermatophagoides pteronyssinus-induced late-phase airway inflammation in patients withallergic rhinitis and asthma.
// Inflammation. . ‒ 2012. ‒ V. 35, № 4. ‒ P. 1600-1609.LeBlanc A., Robichaud P., Lacasse Y., Boulet L.-P. Quantification of asthma control:validation of the Asthma Control Scoring System. // Allergy. ‒ 2007. ‒ V. 62, № 2. ‒ P.120-125.Leem J. H., Kim J. H., Lee K. H., Hong Y., Lee K. H., Kang D., Kwon H. J. Asthma attackassociated with oxidative stress by exposure to ETS and PAH // J Asthma. ‒ 2005. ‒ V. 42,№ 6. ‒ P. 463-467.Lemanske R.
F. Inflammation in childhood asthma and other wheezing disorders //Pediatrics. ‒ 2002. ‒ V. 109, № 2 Suppl. ‒ P. 368-372.Lemanske R. F., Busse W. W. Asthma: Clinical Expression and Molecular Mechanisms. // JAllergy Clin Immunol. . ‒ 2010. ‒ V. 125 №2 Suppl 2. ‒ P. 95-102.Lewis M. J., Short A. L., Lewis K. E. Autonomic nervous system control of thecardiovascular and respiratory systems in asthma // Respir Med. ‒ 2006.
‒ V. 100, № 10. ‒P. 1688-705.Lim K. G., Mottram C. The use of fraction of exhaled nitric oxide in pulmonary practice //Chest. ‒ 2008. ‒ V. 133, № 5. ‒ P. 1232-1242.Litvinets L. Y. The role of vegetative dysregulation in the forming of bronchial asthma inchildren. // Lik Sprava - 2014. ‒ C.
76-81.Liu A. H. Biomarkers and childhood asthma: improving control today and tomorrow. //Allergy Asthma Proc. . ‒ 2005. ‒ V. 26, № 4. ‒ P. 249-54.Liu A. H., Zeiger R. S., Sorkness C., Mahr T., al. e. Development and cross-sectionalvalidation of the Childhood Asthma Control Test. // J Allergy Clin Immunol. . ‒ 2007. ‒ V.119, № 4. ‒ P.
817-825.Lødrup Carlsen K. C., Pijnenburg M. W. Monitoring asthma in childhood. // Eur RespirRev. ‒ 2015 ‒V. 24, № 136. ‒ P. 178-186.Loh L. C., Kanabar V., D’Amato M., al. e. Sputum induction in corticosteroid-dependantasthmatics: risks and airway cellular profile. // Asian Pac J Allergy Immunol. ‒ 2005.
‒ V.23. ‒ P. 189-196.Lopes C., Fonseca J., Delgado L., Moreira A., Barros R., Moreira P., Castelo-Branco MdaG. Assessing asthma control: questionnaires and exhaled nitric oxide providecomplementary information // Eur Respir J. ‒ 2008. ‒ V. 32, № 5. ‒ P. 1419-20.Louhelainen N., Myllarniemi M., Rahman I., Kinnula V. L. Airway biomarkers of theoxidant burden in asthma and chronic obstructive pulmonary disease: current and futureperspectives // Int J Chron Obstruct Pulmon Dis. ‒ 2008. ‒ V.
3, № 4. ‒ P. 585-603.Louhelainen N., Rytila P., Obase Y., Makela M., Haahtela T., Kinnula V. L., Pelkonen A.The value of sputum 8-isoprostane in detecting oxidative stress in mild asthma // J Asthma.‒ 2008. ‒ V. 45, № 2. ‒ P. 149-54.Lu M., Wu B., Che D., al. E. FeNO and asthma treatment in children: a systematic reviewand meta-analysis. // Medicine (Baltimore).
‒ 2015. ‒ V. 94, № 4. – P. e347. – doi:10.1097/MD.0000000000000347.Luijk B., Lindemans C. A., Kanters D., Bertics P., Lammers J. W., Bates M. E.,Koenderman L. Gradual increase in priming of human eosinophils during extravasationfrom peripheral blood to the airways in response to allergen challendge. // J Allergy ClinImmunol. ‒ 2005.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
